SciELO - Scientific Electronic Library Online

 
vol.11 número4Síndrome de transfusão feto-fetalAbordagem de endometriose vesical índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Acta Obstétrica e Ginecológica Portuguesa

versão impressa ISSN 1646-5830

Resumo

CRUZ, Joana  e  COSTA, Ana Rosa. Levonorgestrel-releasing intrauterine system and breast cancer. Acta Obstet Ginecol Port [online]. 2017, vol.11, n.4, pp.276-282. ISSN 1646-5830.

Levonorgestrel intrauterine system (LNG-IUS) is a highly effective long-term contraception that causes endometrial suppression with considerably lower systemic exposure than oral progesterone. It is currently approved for the treatment of abnormal uterine bleeding, dysmenorrhea, for endometrial protection during estrogen therapy and its use in patients with breast cancer taking tamoxifen (TMX) is being debated. The aim of this systematic review was to describe the risk of breast cancer in LNG-IUS users and to define it safety in women taking adjuvant TMX following breast cancer, for the outcomes of endometrial and uterine pathology and secondary breast cancer events

Palavras-chave : Intrauterine device; Medicated intrauterine device; levonorgestrel-releasing intrauterine system; Breast neoplasm; Breast cancer.

        · texto em Português     · Português ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons